Updates on Management of Gastric Cancer

被引：386
作者：
Johnston, Fabian M. [1 ]
Beckman, Michael [2 ]
机构：
[1] Johns Hopkins Univ, Div Surg Oncol, Peritoneal Surface Malignancy Program, Sect Gastrointestinal Surg Oncol, 600 N Wolfe St Blalock 606, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ Hosp, Dept Surg, 600 N Wolfe St Blalock 665, Baltimore, MD 21287 USA
来源：
CURRENT ONCOLOGY REPORTS | 2019年 / 21卷 / 08期
关键词：
Gastric cancer; Gastric adenocarcinoma; Siewert type III; FLOT; HIPEC; CYTO-CHIP; PHASE-III TRIAL; ENDOSCOPIC MUCOSAL RESECTION; CYTOREDUCTIVE SURGERY; PERITONEAL CARCINOMATOSIS; DOUBLE-BLIND; CHEMOTHERAPY; THERAPY; ADENOCARCINOMA; LYMPHADENECTOMY; METAANALYSIS;
D O I：
10.1007/s11912-019-0820-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose of ReviewGastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common, even with complete resection.Recent FindingsAdvances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherapy and chemoradiation, and targeted and immune therapies have led to the current multidisciplinary approach to gastric adenocarcinoma.SummaryTreatment of gastric cancer is rapidly evolving in an effort to combat this challenging disease.
引用
收藏
页数：9
相关论文
共 55 条
  • [1] Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.
    Al-Batran, Salah-Eddin
    Homann, Nils
    Schmalenberg, Harald
    Knopp, Hans-Georg
    Georg
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Biohydrogen Production as a Clean Fuel by Acid and Alkaline Pretreated Mixed Culture During Glucose Fermentation
    Amin, Mohammad Mehdi
    Ghasemian, Mohammad
    Bina, Bijan
    Taheri, Ensiyeh
    Fatehizadeh, Ali
    [J]. HEALTH SCOPE, 2019, 8 (02):
  • [3] [Anonymous], 1973, Jpn J Surg, V3, P61
  • [4] [Anonymous], NCCN GUIDELINES VERS
  • [5] Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
    Bang, Y. -J.
    Ruiz, E. Yanez
    Van Cutsem, E.
    Lee, K. -W.
    Wyrwicz, L.
    Schenker, M.
    Alsina, M.
    Ryu, M. -H.
    Chung, H. -C.
    Evesque, L.
    Al-Batran, S. -E.
    Park, S. H.
    Lichinitser, M.
    Boku, N.
    Moehler, M. H.
    Hong, J.
    Xiong, H.
    Hallwachs, R.
    Conti, I.
    Taieb, J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (10) : 2052 - 2060
  • [6] Bang YJ, 2010, LANCET, V376, P1302
  • [7] Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
    Bang, Yung-Jue
    Cho, Jae Yong
    Kim, Yeul Hong
    Kim, Jin Won
    Di Bartolomeo, Maria
    Ajani, Jaffer A.
    Yamaguchi, Kensei
    Balogh, Agnes
    Sanchez, Teresa
    Moehler, Markus
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5671 - 5678
  • [8] Comprehensive molecular characterization of gastric adenocarcinoma
    Bass, Adam J.
    Thorsson, Vesteinn
    Shmulevich, Ilya
    Reynolds, Sheila M.
    Miller, Michael
    Bernard, Brady
    Hinoue, Toshinori
    Laird, Peter W.
    Curtis, Christina
    Shen, Hui
    Weisenberger, Daniel J.
    Schultz, Nikolaus
    Shen, Ronglai
    Weinhold, Nils
    Keiser, David P.
    Bowlby, Reanne
    Sipahimalani, Payal
    Cherniack, Andrew D.
    Getz, Gad
    Liu, Yingchun
    Noble, Michael S.
    Pedamallu, Chandra
    Sougnez, Carrie
    Taylor-Weiner, Amaro
    Akbani, Rehan
    Lee, Ju-Seog
    Liu, Wenbin
    Mills, Gordon B.
    Yang, Da
    Zhang, Wei
    Pantazi, Angeliki
    Parfenov, Michael
    Gulley, Margaret
    Piazuelo, M. Blanca
    Schneider, Barbara G.
    Kim, Jihun
    Boussioutas, Alex
    Sheth, Margi
    Demchok, John A.
    Rabkin, Charles S.
    Willis, Joseph E.
    Ng, Sam
    Garman, Katherine
    Beer, David G.
    Pennathur, Arjun
    Raphael, Benjamin J.
    Wu, Hsin-Ta
    Odze, Robert
    Kim, Hark K.
    Bowen, Jay
    [J]. NATURE, 2014, 513 (7517) : 202 - 209
  • [9] CYTO-CHIP: Cytoreductive surgery versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A propensity-score analysis from BIG RENAPE and FREGAT working groups.
    Bonnot, Pierre Emmanuel
    Piessen, Guillaume
    Pocard, Marc
    Meunier, Bernard
    Bereder, Jean Marc
    Abboud, Karine
    Marchal, Frederic
    Quenet, Francois
    Goere, Diane
    Msika, Simon
    Arvieux, Catherine
    Pirro, Nicolas
    Wernert, Romuald
    Rat, Patrick
    Pezet, Denis
    Lefevre, Jeremie
    Courvoisier, Thomas
    Kianmanesh, Reza
    Meeus, Pierre
    Glehen, Olivier
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
    Cats, Annemieke
    Jansen, Edwin P. M.
    van Grieken, Nicole C. T.
    Sikorska, Karolina
    Lind, Pehr
    Nordsmark, Marianne
    Kranenbarg, Elma Meershoek-Klein
    Boot, Henk
    Trip, Anouk K.
    Swellengrebel, H. A. Maurits
    van Laarhoven, Hanneke W. M.
    Putter, Hein
    van Sandick, Johanna W.
    Henegouwen, Mark I. van Berge
    Hartgrink, Henk H.
    van Tinteren, Harm
    van de Velde, Cornelis J. H.
    Verheij, Marcel
    [J]. LANCET ONCOLOGY, 2018, 19 (05) : 616 - 628
123456